35052545|t|Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons.
35052545|a|Stress seems to contribute to Parkinson's disease (PD) neuropathology, probably by dysregulation of the hypothalamic-pituitary-adrenal axis. Key factors in this pathophysiology are oxidative stress and mitochondrial dysfunction and neuronal glucocorticoid-induced toxicity. The insulin-like growth factor II (IGF-II), a pleiotropic hormone, has shown antioxidant and neuroprotective effects in some neurodegenerative disorders. Our aim was to examine the protective effect of IGF-II on a dopaminergic cellular combined model of PD and mild to moderate stress measuring oxidative stress parameters, mitochondrial and neuronal markers, and signalling pathways. IGF-II counteracts the mitochondrial-oxidative damage produced by the toxic synergistic effect of corticosterone and 1-methyl-4-phenylpyridinium, protecting dopaminergic neurons from death and neurodegeneration. IGF-II promotes PKC activation and nuclear factor (erythroid-derived 2)-like 2 antioxidant response in a glucocorticoid receptor-dependent pathway, preventing oxidative cell damage and maintaining mitochondrial function. Thus, IGF-II is a potential therapeutic tool for treatment and prevention of disease progression in PD patients suffering mild to moderate emotional stress.
35052545	0	29	Insulin-like Growth Factor II	Gene	3481
35052545	91	106	Neuronal Damage	Disease	MESH:D009410
35052545	123	130	Neurons	Disease	MESH:D009410
35052545	162	181	Parkinson's disease	Disease	MESH:D010300
35052545	183	185	PD	Disease	MESH:D010300
35052545	334	359	mitochondrial dysfunction	Disease	MESH:D028361
35052545	396	404	toxicity	Disease	MESH:D064420
35052545	410	439	insulin-like growth factor II	Gene	3481
35052545	441	447	IGF-II	Gene	3481
35052545	531	558	neurodegenerative disorders	Disease	MESH:D019636
35052545	608	614	IGF-II	Gene	3481
35052545	660	662	PD	Disease	MESH:D010300
35052545	791	797	IGF-II	Gene	3481
35052545	814	844	mitochondrial-oxidative damage	Disease	MESH:D028361
35052545	889	903	corticosterone	Chemical	MESH:D003345
35052545	908	935	1-methyl-4-phenylpyridinium	Chemical	MESH:D015655
35052545	961	968	neurons	Disease	MESH:D009410
35052545	984	1001	neurodegeneration	Disease	MESH:D019636
35052545	1003	1009	IGF-II	Gene	3481
35052545	1019	1022	PKC	Gene	112476
35052545	1038	1081	nuclear factor (erythroid-derived 2)-like 2	Gene	4780
35052545	1108	1131	glucocorticoid receptor	Gene	2908
35052545	1230	1236	IGF-II	Gene	3481
35052545	1324	1326	PD	Disease	MESH:D010300
35052545	1327	1335	patients	Species	9606
35052545	Negative_Correlation	MESH:D015655	MESH:D009410
35052545	Positive_Correlation	MESH:D015655	MESH:D028361
35052545	Negative_Correlation	MESH:D003345	MESH:D009410
35052545	Association	MESH:D003345	MESH:D015655
35052545	Association	MESH:D003345	MESH:D019636
35052545	Negative_Correlation	MESH:D009410	3481
35052545	Positive_Correlation	3481	4780
35052545	Negative_Correlation	MESH:D028361	3481
35052545	Negative_Correlation	MESH:D019636	3481
35052545	Association	MESH:D010300	3481
35052545	Positive_Correlation	112476	3481
35052545	Association	2908	3481
35052545	Positive_Correlation	MESH:D003345	MESH:D028361

